Table 2.
Sequence variation |
14408C>T (RdRp: p.Pro312Leu) |
22189_22191delTAT (S: p.Ile210del) |
22992G>A (S: p.Ser477Asn) |
23403A>G (S: p.Asp614Gly) |
25563G>T (ORF3a: p.Gln57His) |
28688T>C (N: p.Leu139Phe) |
28835T>C (N: p.Ser188Pro) |
28854C>T (N: p.Ser194Leu) |
28881G>A (N: p.Arg203Lys) |
28882G>A (N: p.Arg203Arg) |
28883G>C (N: p.Gly204Arg) |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
Associated haplotype*/Virus strain** |
H1/G |
H1/G |
H1b/GH |
H5 |
H5 linked |
H1b linked |
H1a/GR |
H1a/GR |
H1a/GR |
|||
Variation ID | V1 | V2 | V3 | V4 | V5 | V6 | V7 | V8 | V9 | V10 | V11 | |
Genome type# | No. Samples in Tehran (Total: 50) | |||||||||||
A (=H1a) | 13 | + | . | + | . | . | . | . | + | + | + | |
H1b | 1 (T-35) | + | . | + | + | . | . | . | . | . | . | |
B (=H1b+V8)@ | 8 | + | . | . | + | + | . | . | + | . | . | . |
C (=H1b+V2+V8)@ | 21 | + | + | . | + | + | . | . | + | . | . | . |
Tehran samples proposed to be infected with viruses whose genomes are products of recombination | ||||||||||||
No. Samples (ID) | ||||||||||||
D | 1 (T-47) | + | . | + | . | + | + | . | . | . | . | |
E | 1 (T-51) | + | . | + | . | . | . | + | . | . | . | |
F | 1 (T-3) | + | + | + | . | . | . | . | + | + | + | |
G | 1 (T-42) | + | + | + | + | . | . | + | . | . | . | |
H | 1 (T-18) | + | + | + | + | + | . | . | + | . | . | . |
I | 1 (T-4) | + | + | . | + | + | . | . | . | . | . | . |
Rasht samples proposed to be infected with two viruses and/or with viruses whose genomes are products of recombination | ||||||||||||
D | 1 (R-4) | + | . | + | . | + | + | . | . | . | . | |
D and J | 1 (R-3) | + | . | + | G/T | + | + | . | . | . | . | |
D and K | 2 (R-1 & R-2) | C/T | . | + | . | + | + | . | . | . | . | |
Other samples from provinces outside of Tehran | ||||||||||||
Rasht | 46 samples | + | + | |||||||||
Ahvaz | 50 samples | + | + | |||||||||
Kashan | 12 samples | + | + | |||||||||
Tabriz | 12 samples | + | + | |||||||||
Kermanshah | 12 samples | + | + | |||||||||
Shiraz | 12 samples | + | + |
X, Summary of data presented in Table S2; *, Haplotypes described in Safari et al, (2021a); **, virus strains described in GISAID; #, each type refers to a genome with a unique combination of sequence variations; @, number of sequences with and without the variant nucleotide at position V2 extrapolated on basis of results on 12 samples in which amplicon 2 was amplified and sequenced.
+: variant sequence:., reference sequence, empty cell: not sequenced.